13F-HR filed by JGP Global Gestao de Recursos Ltda.
JGP Global Gestao de Recursos Ltda. filed this 13F-HR for the quarter ended 2018-03-31, filed 2018-04-17, with 18 holding rows worth $251,365,000.
- Accession
- 0001536562-18-000003
- Filer
- CIK 1536562
- Filed
- 2018-04-17
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2018
A holdings report, 18 entries on the cover page, a total value of $251,365,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $251,365,000 with VALUE read as thousands by filing date, 13F file number 028-16384. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| SPY | 78462F103 | SHS | 700,000 | $182,784,000 | thousands by filing date | |
| BANCO MACRO S A | 05961W105 | SPON ADR B | 192,736 | $20,810,000 | thousands by filing date | |
| VANECK ETF TRUST | 92189F676 | COM | 200,000 | $20,616,000 | thousands by filing date | |
| KRAFT HEINZ CO COM | 500754106 | Stock | 200,000 | $12,173,000 | thousands by filing date | |
| ANHEUSER BUSCH INBEV SA NV SPONSORED ADR | 03524A108 | ADR | 42,213 | $4,641,000 | thousands by filing date | |
| INCYTE CORP COM | 45337C102 | Stock | 20,427 | $1,702,000 | thousands by filing date | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 18,506 | $1,500,000 | thousands by filing date | |
| TECHNIPFMC PLC COM | G87110105 | Stock | 50,150 | $1,477,000 | thousands by filing date | |
| SEATTLE GENETICS INC | 812578102 | COM | 22,334 | $1,169,000 | thousands by filing date | |
| ASSEMBLY BIOSCIENCES INC | 045396108 | COM | 17,096 | $840,000 | thousands by filing date | |
| AERIE PHARMACEUTICALS INC | 00771V108 | COM | 13,844 | $751,000 | thousands by filing date | |
| Bristol-Myers Squibb Company | 110122108 | COM | 10,340 | $654,000 | thousands by filing date | |
| AMICUS THERAPEUTICS INC | 03152W109 | COM | 37,773 | $568,000 | thousands by filing date | |
| EXELIXIS INC COM | 30161Q104 | Stock | 22,020 | $488,000 | thousands by filing date | |
| Boston Scientific Corporation | 101137107 | COM | 15,302 | $418,000 | thousands by filing date | |
| ACADIA PHARMACEUTICALS INC | 004225108 | COM | 12,273 | $276,000 | thousands by filing date | |
| EPIZYME INC | 29428V104 | COM | 15,333 | $272,000 | thousands by filing date | |
| IMMUNOMEDICS INC | 452907108 | COM | 15,474 | $226,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001536562-18-000003 | this filing | 2018-04-17 | acceptance time not in the bulk data set |